CIK 0001840229 · <br>Emerging growth company
MiNK Therapeutics, Inc.
Sign in to watch- Ticker
- INKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 212-994-8250
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $73,265
- in 1 filing
Net −$73,265. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Ryan Barbara Director | Grant or award | +1,629 | $10.90 | $18K | 22,035 |
| 2026-03-02 | Corvese Brian Director | Grant or award | +1,640 | $10.90 | $18K | 51,693 |
| 2026-03-02 | Behner Peter Director | Grant or award | +1,491 | $10.90 | $16K | 21,606 |
| 2026-03-02 | WIINBERG ULF Director | Grant or award | +1,285 | $10.90 | $14K | 21,519 |
| 2026-03-02 | Ryan Barbara Director | Sale | −100 | $10.83 | $1K | 21,906 |
| 2026-02-27 | Ryan Barbara Director | Sale | −400 | $10.86 | $4K | 22,006 |
| 2026-01-02 | Buell Jennifer Chief Executive Officer | Shares withheld for taxes | −10,024 | $11.12 | $111K | 57,942 |
| 2026-01-02 | Buell Jennifer Chief Executive Officer | Grant or award | +31,474 | $11.12 | $350K | 67,966 |
| 2026-01-02 | Buell Jennifer Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-01-02 | WIINBERG ULF Director | Grant or award · Stock Option (Right to Buy) | +5,395 | 5,395 | ||
| 2026-01-02 | Ryan Barbara Director | Grant or award · Stock Option (Right to Buy) | +5,395 | 5,395 | ||
| 2026-01-02 | Corvese Brian Director | Grant or award · Stock Option (Right to Buy) | +5,395 | 5,395 | ||
| 2026-01-02 | Behner Peter Director | Grant or award · Stock Option (Right to Buy) | +5,395 | 5,395 | ||
| 2025-12-01 | Corvese Brian Director | Grant or award | +1,612 | $11.09 | $18K | 50,053 |
| 2025-12-01 | Behner Peter Director | Grant or award | +1,466 | $11.09 | $16K | 20,115 |
| 2025-12-01 | Holcomb John Bradley Director | Grant or award | +1,128 | $11.09 | $13K | 1,128 |
| 2025-12-01 | Ryan Barbara Director | Grant or award | +1,601 | $11.09 | $18K | 22,406 |
| 2025-12-01 | Kadlec Robert Peter Director | Grant or award | +1,218 | $11.09 | $14K | 19,126 |
| 2025-12-01 | WIINBERG ULF Director | Grant or award | +1,263 | $11.09 | $14K | 20,234 |
| 2025-09-23 | Holcomb John Bradley Director | Grant or award · Stock Option (Right to Buy) | +4,174 | 4,174 |
Page 2 of 7 · 126 trades